The emerging therapy of the medication represents a major advance in the handling of diabetes mellitus type 2. Different to existing therapies, tirzepatide impacts multiple pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatidepeptide619558.mdkblog.com/48182642/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment